Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
Grymonprez M De Backer TL, Bertels X, Steurbaut S and Lahousse L. Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study. Front. Pharmacol. 2023.14:1125576. doi: 10.3389/fphar.2023.1125576
Abstrak
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)